Les bases moléculaires de la mucoviscidose en France: Plus de 300 mutations et 506 génotypes différents sont en cause

Medecine/Sciences

Volumn 14, Issue 12, 1998, Pages 1413-1421

  Des Georges, Marie ^a,u   Guittard, Caroline ^t   Bozon, Dominique ^s   Chevalier, Françoise ^r   Verlingue, Claudine ^q   Ferec, Claude ^p   Girodon, Emmanuelle ^o   Cazeneuve, Cécile ⁿ   Bienvenu, Thierry ^m   Lalau, Guy ^l   Dumur, Viviane ^k   Feldmann, Delphine ^a   Bieth, Eric ^j   Blayau, Martine ⁱ   Clavel, Christùie ^h   Creveaux, Isabelle ^g   Malinge, Marie Claire ^f   Monnier, Nicole ^e   Malzac, Perrine ^a   Mittre, Hervé ^d   Bonnefont, Jean Paul ^a   Iron, Albert ^c   Chomel, Jean Claude ^a   Chery, Michèle ^b   Claustres, Mireille ^a   more..

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b Institute of Biology   (France)

^c INSTITUTE OF HUMAN GENETICS   (France)

^d HÔPITAL DEBROUSSE   (France)

^e ETSBO   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g Hôpital Trousseau ^*  (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ ARMAND TROUSSEAU HOSPITAL   (France)

^j CHU PURPAN   (France)

^k PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^l HÔPITAL MAISON BLANCHE   (France)

^m UNIVERSITÉ CLERMONT AUVERGNE   (France)

ⁿ ANGERS UNIVERSITY HOSPITAL   (France)

^o CHU La Tronche and University   (France)

^p TIMONE HOSPITAL   (France)

^q CHU Clemenceau   (France)

^r HÔPITAL NECKER ENFANTS MALADES   (France)

^s HÔPITAL PELLEGRIN   (France)

^t POITIERS UNIVERSITY HOSPITAL   (France)

^u CHU NANCY BRABOIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; ETHNIC DIFFERENCE; FRANCE; GENE FREQUENCY; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; REVIEW;

EID: 0032414799     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/984     Document Type: Article

References (17)

1. Kerem BS, RommensJM, Buchanam JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245: 1073-80.
2. Riordan JR, RommensJM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-73.
3. RommensJM, lannnzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-65.
4. Cystic Fibrosis Genetic Analysis Consortium. Population variation of common cystic fibrosis mutations. Hum Mut 1994; 4: 167-77.
5. Estivill X, Bancells C, Ranios C, and the Biomed CF Mutation Analysis Consortium. Geographic distribution and regional origin of 2/2 cystic fibrosis mutations in European populations. Hum Mut 1997; 10: 135-54.
6. Beandet AL, Tsui LC. A suggested nomenclature for designating mutations. Hum Mutât 1996; 2: 24o-8.
7. Antonarakis SE, and the Nomenclature working group. Recommendations for a nomenclature system for human gene mutations. Hum Mutât 1998; 11: 1-3.
8. Dequeker E, Cassiman JJ. Evaluation of CFTTIgene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment. EurJ Hum Genet 1998; 6: 165-75.
9. Cotton RGH, Scriver CR. Proof of disease causing mutation. Hum Mutât 1998; 12: 1-3.
10. Ferec G, Audrezet MP, Mercier B, Guillermit H, Moullier P, Quere I, Verlingue C. Detection of over 98% cystic fibrosis mutations in a Celtic population. Nat Genet 1992; 1: 188-91.
11. Claustres M, Laussei M, Des Georges M, Giansily M, Culard JF, Razakatsara G, Démaille J. Analysis of the 27 exons and flanking regions of the cystis fibrosis gene: 40 different mutations account for 91,2% of the mutant alleles in Southern France. Hum Mol Genet 1993; 2: 1209-13.
12. Fanen P, Ghanem N, Vidaud M, Besmond C, Martin J, Costes B, Plassa F, Coossens M. Molecular characterization of cystic fibrosis: 16 novel mutations identified byanalysis of the whole cystic fibrosis conductance transmembrane regulator (CFTII) coding regions and splice site junctions. Genomes 1992; 13:770-6.
13. Bienvenu T, Cazeneuve C, Kaplan JC, Beldiord C. Mutation heterogeneity of cystic fibrosis in France: screening by denaturing gradient gel electrophoresis using psoralen-modified oligonucleotide. Hum blutât 1995:6:23-9.
14. Chevalier-Porst F, Bonardot AM, Chazalette JP, Mathieu M, Bozon D. 40 kilobase deletion (CF44kbdel4-10) removes exons 4 to 10 of the cystic fibrosis transmembrane conductance regulator gene. Hum Mutât 1998 (Suppl. 1):S291-4.
15. Cuppcns H, Lin W, Jaspers M, Costcs B, Teng H, Vankeerbergnen A, Jorisscn M, Droogmans G, Rcynacrt I, Goossens M, Nillius B, Cassiman JJ. I'olyvariant mutant cystic fibrosis transmcinbrane conductance regulator genes. Tlie polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 1998; 101: 487-96.
16. Estivill X. Complexity in a monogenic disease. Nat Genet 1996; 12: 348-50.
17. Stern RC. The diagnosis of cystic fibrosis. N Engl J Med 1997; 336: 487-91.